FDx Advisors, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 870 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.

Quarter-by-quarter ownership
FDx Advisors, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,601
-46.5%
15,718
-47.0%
0.13%
-18.9%
Q2 2023$2,993
-42.9%
29,664
-48.7%
0.16%
-28.1%
Q1 2023$5,2420.0%57,7870.0%0.23%0.0%
Q4 2022$5,242
-99.9%
57,787
-1.6%
0.23%
+14.0%
Q3 2022$4,464,000
-18.3%
58,723
-9.1%
0.20%
-2.4%
Q2 2022$5,461,000
-0.9%
64,601
+2.8%
0.20%
+9.6%
Q1 2022$5,512,000
+6.9%
62,817
+6.5%
0.19%
+30.8%
Q4 2021$5,158,000
+33.0%
58,970
+24.4%
0.14%
+15.3%
Q3 2021$3,877,000
-3.3%
47,404
+7.9%
0.12%
-6.8%
Q2 2021$4,008,000
+10.6%
43,923
+3.6%
0.13%
-2.9%
Q1 2021$3,624,000
-18.7%
42,394
-10.2%
0.14%
-25.5%
Q4 2020$4,459,000
+20.3%
47,225
+10.8%
0.18%
+5.7%
Q3 2020$3,706,000
+1.3%
42,616
+1.7%
0.17%
-9.4%
Q2 2020$3,659,000
+13.8%
41,898
+7.4%
0.19%
-8.1%
Q1 2020$3,216,000
+0.3%
39,003
+15.2%
0.21%
+18.1%
Q4 2019$3,207,000
+28.5%
33,864
+17.9%
0.18%
+2.3%
Q3 2019$2,495,000
-45.6%
28,713
-42.9%
0.17%
-3.9%
Q2 2019$4,589,000
+16.2%
50,257
+22.4%
0.18%
+12.5%
Q1 2019$3,948,000
+80.7%
41,067
+61.3%
0.16%
-11.1%
Q4 2018$2,185,000
-45.2%
25,463
-45.0%
0.18%
+21.6%
Q3 2018$3,988,000
+16.3%
46,283
+1.9%
0.15%
+19.4%
Q2 2018$3,430,000
-11.6%
45,405
-5.4%
0.12%
+6.9%
Q1 2018$3,881,000
+2.0%
48,005
+6.0%
0.12%
+12.6%
Q4 2017$3,804,000
+15.8%
45,307
+18.4%
0.10%
+14.4%
Q3 2017$3,286,000
+20.2%
38,272
+16.9%
0.09%
+11.1%
Q2 2017$2,733,000
-43.9%
32,736
-50.1%
0.08%
-45.6%
Q1 2017$4,870,000
+4.5%
65,569
+2.5%
0.15%
+11.2%
Q4 2016$4,660,000
+83.4%
63,976
+98.8%
0.13%
+26.4%
Q3 2016$2,541,000
-3.2%
32,186
+1.2%
0.11%
-10.9%
Q2 2016$2,624,000
-1.0%
31,805
-13.1%
0.12%
-1.7%
Q1 2016$2,651,000
-5.2%
36,589
+12.6%
0.12%
-4.7%
Q4 2015$2,796,000
-99.9%
32,496
+12.3%
0.13%
-44.3%
Q3 2015$2,658,801,000
+84710.2%
28,925
-9.6%
0.23%
+46.2%
Q2 2015$3,135,000
+7.6%
32,010
+8.5%
0.16%
+143.8%
Q1 2015$2,913,000
-27.2%
29,500
-31.7%
0.06%
-73.8%
Q4 2014$4,002,000
-4.8%
43,193
-3.3%
0.24%
-10.6%
Q3 2014$4,204,000
-21.0%
44,666
-24.0%
0.27%
-21.6%
Q2 2014$5,320,000
+35.9%
58,761
+27.6%
0.35%
+6.4%
Q1 2014$3,915,000
-6.7%
46,051
-11.8%
0.33%
-21.8%
Q4 2013$4,194,000
-15.1%
52,220
-18.9%
0.42%
-28.3%
Q3 2013$4,941,000
+7.1%
64,406
-1.3%
0.58%
-4.1%
Q2 2013$4,612,00065,2250.61%
Other shareholders
NOVARTIS A G shareholders Q1 2016
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders